Dr Matteo Zignol is the Unit Head of the Prevention, Diagnosis, Treatment, Care and Innovation unit at the WHO Global TB Programme in Geneva, Switzerland. The focus of his unit is to develop policy guidelines throughout the spectrum of TB prevention, screening, diagnosis, treatment and care; shape the TB research agenda; lead the development and publication of global TB research strategies and approaches; and stimulate the generation, translation and dissemination of valuable knowledge.

Dr Zignol has been working at WHO since 2003. In recent years, he led the Research for TB Elimination team and previously he coordinated the Global Project on Anti-Tuberculosis Drug Resistance Surveillance and, as part of it, managed a multi-country project on the use of genetic sequencing for surveillance of drug resistance.

Dr Zignol is an infectious disease specialist and clinical epidemiologist. He holds a MD from the University of Padua, Italy, and an MPH from Johns Hopkins University, Baltimore, US. He has contributed to several peer reviewed publications on different topics in peer review journals and has written several book chapters.